nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—OPRK1—female reproductive system—cervical cancer	0.0112	0.0357	CbGeAlD
Mianserin—HTR2B—uterine cervix—cervical cancer	0.00879	0.0279	CbGeAlD
Mianserin—HTR2B—decidua—cervical cancer	0.00837	0.0266	CbGeAlD
Mianserin—HTR2B—endometrium—cervical cancer	0.00795	0.0253	CbGeAlD
Mianserin—HTR7—epithelium—cervical cancer	0.00759	0.0241	CbGeAlD
Mianserin—SLC6A2—decidua—cervical cancer	0.00744	0.0236	CbGeAlD
Mianserin—HTR1A—renal system—cervical cancer	0.00737	0.0234	CbGeAlD
Mianserin—HTR2B—uterus—cervical cancer	0.00732	0.0233	CbGeAlD
Mianserin—HTR1D—female reproductive system—cervical cancer	0.00708	0.0225	CbGeAlD
Mianserin—HTR7—renal system—cervical cancer	0.00704	0.0224	CbGeAlD
Mianserin—HTR2C—female reproductive system—cervical cancer	0.00701	0.0223	CbGeAlD
Mianserin—ADRA2C—uterine cervix—cervical cancer	0.00692	0.022	CbGeAlD
Mianserin—SLC6A4—female reproductive system—cervical cancer	0.00664	0.0211	CbGeAlD
Mianserin—ADRA2C—decidua—cervical cancer	0.00659	0.0209	CbGeAlD
Mianserin—HTR2B—female reproductive system—cervical cancer	0.00658	0.0209	CbGeAlD
Mianserin—HRH2—lymph node—cervical cancer	0.00649	0.0206	CbGeAlD
Mianserin—ADRA2C—renal system—cervical cancer	0.00647	0.0206	CbGeAlD
Mianserin—ADRA2C—endometrium—cervical cancer	0.00626	0.0199	CbGeAlD
Mianserin—ADRA2C—mammalian vulva—cervical cancer	0.00605	0.0192	CbGeAlD
Mianserin—HTR2B—vagina—cervical cancer	0.00595	0.0189	CbGeAlD
Mianserin—SLC6A2—female reproductive system—cervical cancer	0.00585	0.0186	CbGeAlD
Mianserin—ADRA2C—uterus—cervical cancer	0.00576	0.0183	CbGeAlD
Mianserin—HRH1—epithelium—cervical cancer	0.00567	0.018	CbGeAlD
Mianserin—HTR7—female reproductive system—cervical cancer	0.00564	0.0179	CbGeAlD
Mianserin—HRH1—uterine cervix—cervical cancer	0.00562	0.0179	CbGeAlD
Mianserin—CYP1A2—renal system—cervical cancer	0.00561	0.0178	CbGeAlD
Mianserin—ADRA2A—uterine cervix—cervical cancer	0.00552	0.0175	CbGeAlD
Mianserin—CYP2B6—renal system—cervical cancer	0.00538	0.0171	CbGeAlD
Mianserin—HRH1—decidua—cervical cancer	0.00535	0.017	CbGeAlD
Mianserin—ADRA2A—decidua—cervical cancer	0.00526	0.0167	CbGeAlD
Mianserin—HRH1—endometrium—cervical cancer	0.00508	0.0161	CbGeAlD
Mianserin—ADRA2A—endometrium—cervical cancer	0.00499	0.0159	CbGeAlD
Mianserin—HRH1—mammalian vulva—cervical cancer	0.00492	0.0156	CbGeAlD
Mianserin—ADRA2A—mammalian vulva—cervical cancer	0.00483	0.0153	CbGeAlD
Mianserin—HTR2A—epithelium—cervical cancer	0.00473	0.015	CbGeAlD
Mianserin—ADRA2C—female gonad—cervical cancer	0.00472	0.015	CbGeAlD
Mianserin—ADRA2C—vagina—cervical cancer	0.00469	0.0149	CbGeAlD
Mianserin—ADRA2A—uterus—cervical cancer	0.0046	0.0146	CbGeAlD
Mianserin—HTR2A—renal system—cervical cancer	0.00439	0.0139	CbGeAlD
Mianserin—CYP2B6—female reproductive system—cervical cancer	0.00431	0.0137	CbGeAlD
Mianserin—HRH1—female reproductive system—cervical cancer	0.00421	0.0134	CbGeAlD
Mianserin—ADRA2A—female reproductive system—cervical cancer	0.00413	0.0131	CbGeAlD
Mianserin—CYP3A4—renal system—cervical cancer	0.00406	0.0129	CbGeAlD
Mianserin—CYP2D6—renal system—cervical cancer	0.004	0.0127	CbGeAlD
Mianserin—CYP2B6—vagina—cervical cancer	0.0039	0.0124	CbGeAlD
Mianserin—HTR2B—lymph node—cervical cancer	0.00385	0.0122	CbGeAlD
Mianserin—HRH1—female gonad—cervical cancer	0.00383	0.0122	CbGeAlD
Mianserin—HRH1—vagina—cervical cancer	0.00381	0.0121	CbGeAlD
Mianserin—ADRA2A—female gonad—cervical cancer	0.00376	0.012	CbGeAlD
Mianserin—ADRA2A—vagina—cervical cancer	0.00374	0.0119	CbGeAlD
Mianserin—HTR2A—female reproductive system—cervical cancer	0.00352	0.0112	CbGeAlD
Mianserin—SLC6A2—lymph node—cervical cancer	0.00342	0.0109	CbGeAlD
Mianserin—CYP3A4—female reproductive system—cervical cancer	0.00325	0.0103	CbGeAlD
Mianserin—CYP2D6—female reproductive system—cervical cancer	0.0032	0.0102	CbGeAlD
Mianserin—HTR2A—vagina—cervical cancer	0.00318	0.0101	CbGeAlD
Mianserin—ADRA2C—lymph node—cervical cancer	0.00303	0.00963	CbGeAlD
Mianserin—CYP2D6—female gonad—cervical cancer	0.00291	0.00926	CbGeAlD
Mianserin—HRH1—lymph node—cervical cancer	0.00246	0.00783	CbGeAlD
Mianserin—ADRA2A—lymph node—cervical cancer	0.00242	0.00769	CbGeAlD
Mianserin—HTR7—Signaling Pathways—WNT5A—cervical cancer	0.0004	0.000584	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—WNT5A—cervical cancer	0.000398	0.00058	CbGpPWpGaD
Mianserin—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000395	0.000576	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000395	0.000576	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.000394	0.000575	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000394	0.000575	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000391	0.000571	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000389	0.000568	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—HES1—cervical cancer	0.000388	0.000566	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—WNT2—cervical cancer	0.000379	0.000553	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—NOTCH2—cervical cancer	0.000367	0.000535	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—WNT5A—cervical cancer	0.000366	0.000534	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—HES1—cervical cancer	0.000358	0.000522	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	0.000356	0.000519	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CA9—cervical cancer	0.000347	0.000507	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000344	0.000501	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000344	0.000501	CbGpPWpGaD
Mianserin—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000343	0.0005	CbGpPWpGaD
Mianserin—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000342	0.000499	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000342	0.000499	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.00034	0.000497	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TERT—cervical cancer	0.00034	0.000496	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000338	0.000493	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000337	0.000492	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000332	0.000485	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CA9—cervical cancer	0.000326	0.000475	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TERT—cervical cancer	0.000314	0.000458	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—FGFR3—cervical cancer	0.000312	0.000455	CbGpPWpGaD
Mianserin—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000309	0.00045	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000308	0.000449	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000307	0.000448	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000302	0.00044	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—HES1—cervical cancer	0.000301	0.000439	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000297	0.000433	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000297	0.000433	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000296	0.000432	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000295	0.000431	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—NOTCH1—cervical cancer	0.000293	0.000427	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—FGFR3—cervical cancer	0.000288	0.00042	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000287	0.000419	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NOTCH2—cervical cancer	0.000285	0.000416	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NOTCH2—cervical cancer	0.000281	0.00041	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NOTCH2—cervical cancer	0.000281	0.00041	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.000279	0.000407	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—NOTCH1—cervical cancer	0.00027	0.000394	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.00027	0.000394	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TERT—cervical cancer	0.000263	0.000384	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—EGFR—cervical cancer	0.000261	0.000381	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.00026	0.00038	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000257	0.000375	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000256	0.000374	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000256	0.000373	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—FGFR3—cervical cancer	0.000242	0.000353	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—EGFR—cervical cancer	0.000241	0.000351	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000239	0.000349	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HES1—cervical cancer	0.000234	0.000341	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000233	0.00034	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HES1—cervical cancer	0.000231	0.000336	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HES1—cervical cancer	0.00023	0.000336	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HES1—cervical cancer	0.000229	0.000334	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—NOTCH1—cervical cancer	0.000227	0.000331	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CA9—cervical cancer	0.000226	0.00033	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—MTOR—cervical cancer	0.000219	0.00032	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000216	0.000315	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HES1—cervical cancer	0.00021	0.000307	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000208	0.000304	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000207	0.000302	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TERT—cervical cancer	0.000205	0.000299	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—MTOR—cervical cancer	0.000202	0.000295	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—EGFR—cervical cancer	0.000202	0.000295	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TERT—cervical cancer	0.000202	0.000295	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TERT—cervical cancer	0.000202	0.000294	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—CASP3—cervical cancer	0.000202	0.000294	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.000201	0.000294	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TERT—cervical cancer	0.000201	0.000293	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HES1—cervical cancer	0.000196	0.000286	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—CTNNB1—cervical cancer	0.000194	0.000284	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CA9—cervical cancer	0.000192	0.00028	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—FGFR3—cervical cancer	0.000188	0.000275	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CASP3—cervical cancer	0.000186	0.000272	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—FGFR3—cervical cancer	0.000185	0.000271	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—FGFR3—cervical cancer	0.000185	0.00027	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TERT—cervical cancer	0.000184	0.000269	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.000184	0.000268	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000183	0.000267	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.00018	0.000262	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—CTNNB1—cervical cancer	0.000179	0.000262	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000179	0.000262	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000177	0.000258	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NOTCH1—cervical cancer	0.000177	0.000258	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NOTCH1—cervical cancer	0.000174	0.000254	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—TP53—cervical cancer	0.000174	0.000254	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NOTCH1—cervical cancer	0.000174	0.000254	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000174	0.000253	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000173	0.000252	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TERT—cervical cancer	0.000172	0.00025	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000171	0.000249	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—MTOR—cervical cancer	0.00017	0.000248	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HES1—cervical cancer	0.00017	0.000248	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—STAT3—cervical cancer	0.00017	0.000247	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.000169	0.000247	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HES1—cervical cancer	0.000165	0.000241	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000164	0.000239	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—TP53—cervical cancer	0.000163	0.000237	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	0.000159	0.000232	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000157	0.00023	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—EGFR—cervical cancer	0.000157	0.00023	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—STAT3—cervical cancer	0.000156	0.000228	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CASP3—cervical cancer	0.000156	0.000228	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—EGFR—cervical cancer	0.000155	0.000226	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TERT—cervical cancer	0.000155	0.000226	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—EGFR—cervical cancer	0.000155	0.000226	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—EGFR—cervical cancer	0.000154	0.000225	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—EGFR—cervical cancer	0.000154	0.000225	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CTNNB1—cervical cancer	0.000151	0.00022	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HES1—cervical cancer	0.00015	0.000219	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TERT—cervical cancer	0.00015	0.000218	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000149	0.000217	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CA9—cervical cancer	0.000148	0.000216	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000148	0.000216	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000147	0.000215	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HES1—cervical cancer	0.000147	0.000215	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TERT—cervical cancer	0.000145	0.000211	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—EGFR—cervical cancer	0.000142	0.000207	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	0.000142	0.000207	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—EGFR—cervical cancer	0.000142	0.000207	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MTHFR—cervical cancer	0.000141	0.000206	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000137	0.0002	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000137	0.000199	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HES1—cervical cancer	0.000134	0.000196	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	0.000133	0.000195	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	0.000133	0.000194	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MTOR—cervical cancer	0.000132	0.000193	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MTHFR—cervical cancer	0.000132	0.000193	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—TP53—cervical cancer	0.000132	0.000193	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000132	0.000192	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—STAT3—cervical cancer	0.000131	0.000192	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TERT—cervical cancer	0.000131	0.000192	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MTOR—cervical cancer	0.00013	0.00019	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MTOR—cervical cancer	0.00013	0.00019	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MTOR—cervical cancer	0.000129	0.000189	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—TP53—cervical cancer	0.000129	0.000189	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000129	0.000189	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TERT—cervical cancer	0.000129	0.000188	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000129	0.000188	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.000128	0.000187	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	0.000125	0.000182	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CASP3—cervical cancer	0.000122	0.000178	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000121	0.000176	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000175	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CASP3—cervical cancer	0.00012	0.000175	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—EGFR—cervical cancer	0.000119	0.000174	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—cervical cancer	0.000119	0.000174	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MTOR—cervical cancer	0.000119	0.000174	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CASP3—cervical cancer	0.000119	0.000174	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	0.000119	0.000174	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000119	0.000173	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—FGFR3—cervical cancer	0.000118	0.000173	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TERT—cervical cancer	0.000118	0.000172	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CTNNB1—cervical cancer	0.000117	0.000171	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000169	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CTNNB1—cervical cancer	0.000116	0.000169	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000115	0.000168	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	0.000115	0.000167	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.000114	0.000167	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000113	0.000165	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000111	0.000162	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	0.000111	0.000162	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOTCH1—cervical cancer	0.000111	0.000162	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MTOR—cervical cancer	0.000111	0.000162	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CASP3—cervical cancer	0.00011	0.00016	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	0.000108	0.000157	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	0.000106	0.000154	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—STAT3—cervical cancer	0.000102	0.000149	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CASP3—cervical cancer	0.000102	0.000149	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	0.000101	0.000148	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—STAT3—cervical cancer	0.000101	0.000147	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000101	0.000147	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—STAT3—cervical cancer	0.000101	0.000147	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—cervical cancer	0.0001	0.000146	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—STAT3—cervical cancer	0.0001	0.000146	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MTOR—cervical cancer	0.0001	0.000146	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—EGFR—cervical cancer	9.92e-05	0.000145	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—EGFR—cervical cancer	9.9e-05	0.000144	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CTNNB1—cervical cancer	9.82e-05	0.000143	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MTOR—cervical cancer	9.66e-05	0.000141	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MTOR—cervical cancer	9.61e-05	0.00014	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MTOR—cervical cancer	9.34e-05	0.000136	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—EGFR—cervical cancer	9.3e-05	0.000136	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—STAT3—cervical cancer	9.2e-05	0.000134	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP3—cervical cancer	9.2e-05	0.000134	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—cervical cancer	9.19e-05	0.000134	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EGFR—cervical cancer	9.16e-05	0.000134	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EGFR—cervical cancer	9.15e-05	0.000134	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EGFR—cervical cancer	9.09e-05	0.000133	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	9.02e-05	0.000132	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP3—cervical cancer	8.88e-05	0.00013	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	8.87e-05	0.000129	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP3—cervical cancer	8.83e-05	0.000129	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP3—cervical cancer	8.59e-05	0.000125	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—STAT3—cervical cancer	8.56e-05	0.000125	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	8.56e-05	0.000125	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	8.52e-05	0.000124	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MTOR—cervical cancer	8.48e-05	0.000124	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EGFR—cervical cancer	8.36e-05	0.000122	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MTOR—cervical cancer	8.34e-05	0.000122	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MTOR—cervical cancer	8.32e-05	0.000121	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	8.28e-05	0.000121	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—cervical cancer	7.81e-05	0.000114	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—cervical cancer	7.8e-05	0.000114	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—cervical cancer	7.78e-05	0.000114	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—cervical cancer	7.78e-05	0.000114	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—cervical cancer	7.73e-05	0.000113	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—cervical cancer	7.69e-05	0.000112	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—cervical cancer	7.68e-05	0.000112	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—cervical cancer	7.67e-05	0.000112	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—cervical cancer	7.66e-05	0.000112	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—cervical cancer	7.63e-05	0.000111	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MTOR—cervical cancer	7.59e-05	0.000111	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CTNNB1—cervical cancer	7.52e-05	0.00011	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—cervical cancer	7.46e-05	0.000109	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—cervical cancer	7.42e-05	0.000108	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	7.4e-05	0.000108	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CTNNB1—cervical cancer	7.38e-05	0.000108	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—cervical cancer	7.22e-05	0.000105	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—cervical cancer	7.03e-05	0.000103	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—cervical cancer	7.02e-05	0.000102	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—cervical cancer	6.98e-05	0.000102	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—cervical cancer	6.78e-05	9.9e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—cervical cancer	6.75e-05	9.85e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	6.73e-05	9.82e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—cervical cancer	6.56e-05	9.58e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—cervical cancer	6.55e-05	9.56e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—cervical cancer	6.53e-05	9.53e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—cervical cancer	6.45e-05	9.41e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—cervical cancer	6.43e-05	9.39e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—cervical cancer	6.01e-05	8.76e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—cervical cancer	5.95e-05	8.69e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—cervical cancer	5.9e-05	8.61e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—cervical cancer	5.86e-05	8.56e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—cervical cancer	5.86e-05	8.55e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—cervical cancer	5.85e-05	8.53e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—cervical cancer	5.69e-05	8.31e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—cervical cancer	5.66e-05	8.27e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—cervical cancer	5.51e-05	8.04e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—cervical cancer	5.33e-05	7.78e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—cervical cancer	5e-05	7.3e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—cervical cancer	4.92e-05	7.18e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—cervical cancer	4.91e-05	7.16e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—cervical cancer	4.48e-05	6.53e-05	CbGpPWpGaD
